The Ohio Minds Matter collaborative was created to address the complex behavioral healthcare needs of many children on Medicaid. Their parents and caregivers often struggle to understand their health problems and find the right source and types of care. This is particularly the case for children living in foster care. These young people are more likely to experience trauma and social-emotional issues early in life and are prescribed atypical antipsychotic medications more often than other children in Medicaid. Some are prescribed multiple medications outside of accepted standards of care, leading to concern about adverse effects with long-lasting impact.
To evaluate and improve the prescribing patterns of atypical antipsychotics and other psychotropic medications to the youngest members of the Medicaid population, GRC partners with the state of Ohio’s BEACON (Best Evidence Advancing Child health in Ohio Now!) program to convene healthcare leaders, stakeholders, and medical professionals to create new approaches to improve health outcomes of these children.
Over the course of the project, this initiative will:
- Develop technical resources supporting best practice and clinical guidelines for safe and effective use of psychotropic medications under the guidance of a panel consisting of Ohio and national psychiatric experts;
- Improve the use of best practices and appropriate clinical guidelines for psychotropic medications by offering second opinion consultation, educational outreach and technical support to Medicaid providers who are considering initiating psycho-pharmacological treatment or who are currently prescribing psychotropic medications in their practices; and
- Advance the knowledge and understanding of parents or caregivers of pediatric patients and child-serving workers from schools and child-welfare systems regarding the safe and effective use of psychotropic medications by developing targeted resources.
To achieve these goals, an Ohio Statewide Clinical Advisory Panel has developed a tool kit that sets forth guidelines and best practices for the use of psychotropic medications in Ohio. In three diverse pilot communities, teams of healthcare and community service professionals will implement the tool kit to identify processes in their communities for improvement and design and test community-specific interventions. Ohio will use the pilot sites’ findings to support the collaborative’s goal to transform healthcare provider prescribing patterns of atypical antipsychotics and other psychotropic medications for the Medicaid population across Ohio.